Senate Bill 0285
| || |
DIGEST OF SB285 (Updated February 2, 2010 4:47 pm - DI 84)
Sale and tracking of ephedrine. Requires the attorney general to enter into a memorandum of understanding with an entity to provide a pseudoephedrine (PSE) tracking system that meets certain standards. Prohibits a retailer from selling, and a purchaser from purchasing, more than 3.6 grams of ephedrine or pseudoephedrine on one day, or nine grams of ephedrine or pseudoephedrine in a 30 day period. Requires a retailer to electronically transmit certain information concerning the sale of ephedrine and PSE to a statewide PSE tracking system. Specifies that the board of pharmacy shall adopt certain rules concerning a pharmacy that does not comply with PSE tracking requirements. Provides that a retailer must begin entering data into the PSE tracking system not later than 180 days after the attorney general enters into a memorandum of understanding. Requires a retailer who sells drugs containing ephedrine or pseudoephedrine to: (1) post a sign warning that it is a criminal offense for a person to purchase drugs containing more than certain quantities of ephedrine or pseudoephedrine; and (2) require the clerk who is conducting the transaction to personally advise a purchaser that it is a criminal offense for a person to purchase drugs containing more than certain quantities of ephedrine or pseudoephedrine. Provides that, upon request, the clerk who conducts the transaction shall advise the purchaser how many grams of ephedrine or pseudoephedrine are contained in the drugs being purchased. Provides that an exemption to the tracking requirement for persons who do not sell exclusively to walk in customers will now only apply to persons who do not sell to any walk in customers. Requires the state police to report to the legislative council concerning the effectiveness of PSE tracking in reducing the illicit production of methamphetamine.
>Latest Printing > (PDF)
Conference Committee Reports